PD-025Hand-foot syndrome is a biomarker of improved survival following treatment with capecitabine. (2nd July 2019) - Jandu, H; Church, D; Paul, J; Tomlinson, I; Iveson, T; Kerr, R; Kerr, D; Palles, C